Open access
Aug 2026
Integrating perfluorocarbon and type-I photosensitizer into a single molecule: a phenothiazine-based platform for hypoxia-tolerant PDT
Both in vitro and in vivo studies confirm that PFI effectively accumulates in tumors, relieves hypoxia, and achieves potent antitumor efficacy with negligible side effects, offering a facile and robust platform for hypoxia-tolerant photodynamic cancer therapy.
Ziqi Zou, Mei-Ying Liu, Kun Zhang et al.
· RSC Advances · 0 citations